25,000 Shares in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Acquired by Quinn Opportunity Partners LLC

Quinn Opportunity Partners LLC purchased a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 25,000 shares of the medical instruments supplier's stock, valued at approximately $474,000.

Other institutional investors have also recently bought and sold shares of the company. Riverview Trust Co purchased a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. MassMutual Private Wealth & Trust FSB raised its position in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after purchasing an additional 1,232 shares during the last quarter. UMB Bank n.a. lifted its position in shares of DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock worth $28,000 after purchasing an additional 564 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock worth $33,000 after acquiring an additional 1,568 shares during the period. Finally, Signaturefd LLC boosted its holdings in shares of DENTSPLY SIRONA by 513.3% during the 4th quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after buying an additional 3,706 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

Remove Ads

DENTSPLY SIRONA Price Performance

DENTSPLY SIRONA stock traded down $0.53 during trading hours on Tuesday, hitting $12.55. 3,114,940 shares of the stock were exchanged, compared to its average volume of 2,949,863. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $31.13. The stock has a market capitalization of $2.50 billion, a P/E ratio of -6.06, a P/E/G ratio of 1.80 and a beta of 0.92. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The business's 50-day moving average is $15.95 and its two-hundred day moving average is $18.96.

DENTSPLY SIRONA Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 5.10%. DENTSPLY SIRONA's dividend payout ratio is presently -14.07%.

Analysts Set New Price Targets

Several equities research analysts recently commented on XRAY shares. Mizuho reduced their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a report on Thursday, March 13th. Wells Fargo & Company reduced their price objective on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a research note on Friday, February 28th. Needham & Company LLC reiterated a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Robert W. Baird reduced their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating for the company in a report on Friday, February 28th. Finally, Morgan Stanley lowered shares of DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price target for the company. in a research report on Tuesday. Thirteen equities research analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of "Hold" and a consensus target price of $22.58.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of DENTSPLY SIRONA stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company's stock, valued at $1,353,341.21. The trade was a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 0.52% of the company's stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.